Projects per year
Fingerprint
Dive into the research topics where Luna Fredericq is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
ANI360: Evaluating the anti-tumor potential of PARP inhibitor treatment in combination with dendritic cell-based therapies in triple negative breast cancer
Hadadi, E. (Administrative Promotor) & Fredericq, L. (PI (Promotor, Principal Investigator))
1/11/23 → 31/10/24
Project: Fundamental
-
Lipid-based delivery systems for dendritic cell targeting: Formulation strategies and cancer applications
Fredericq, L., Hamouda, A. E. I., Zhong, Z., Van Ginderachter, J. A., De Geest, B. G. & Laoui, D., 10 May 2026, In: Journal of Controlled Release. 393, 24 p., 114799.Research output: Contribution to journal › Article › peer-review
-
Characterization of BRCA1- and BRCA2- deficient triple negative breast cancer models to assess novel treatment strategies
Fredericq, L., 20 May 2024, (Unpublished).Research output: Unpublished contribution to conference › Poster
-
Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity
Hamouda, A. E. I., Filtjens, J., Brabants, E., Kancheva, D., Debraekeleer, A., Brughmans, J., Jacobs, L., Bardet, P. M. R., Knetemann, E., Lefesvre, P., Allonsius, L., Gontsarik, M., Varela, I., Crabbé, M., Clappaert, E. J., Cappellesso, F., Caro, A. A., Peiró, A. G., Fredericq, L. & Hadadi, E. & 9 others, , 6 Dec 2024, In: Nature communications. 15, 1, 20 p., 10635.Research output: Contribution to journal › Article › peer-review
Open AccessFile70 Citations (Scopus)5 Downloads (Pure)
Datasets
-
Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity
Laoui, D. (Creator), Hamouda, A. E. I. (Creator), Filtjens, J. (Creator), Brabants, E. (Creator), Kancheva, D. (Creator), Debraekeleer, A. (Creator), Brughmans, J. (Creator), Jacobs, L. (Creator), Bardet, P. (Creator), Knetemann, E. (Creator), Lefesvre, P. (Creator), Allonsius, L. (Creator), Gontsarik, M. (Creator), Varela, I. (Creator), Crabbé, M. (Creator), Clappaert, E. (Creator), Cappellesso, F. (Creator), Caro, A. A. (Creator), Gordún Peiró, A. (Creator), Fredericq, L. (Creator), Hadadi, E. (Creator), Senti, M. E. (Creator), Schiffelers, R. (Creator), van Grunsven, L. (Creator), Nana, F. A. (Creator), De Geest, B. (Creator), Deschoemaeker, S. (Creator), De Koker, S. (Creator) & Lambolez, F. (Creator), NCBI Gene Expression Omnibus, 12 Nov 2024
Dataset
Prizes
-
European Network of Immunology Institutes | EFIS EJI Travel Grant
Fredericq, L. (Recipient), 18 Mar 2024
Prize: Prize (including medals and awards)
-
NSE Doctoral School Travel Award
Fredericq, L. (Recipient), 28 Feb 2024
Prize: Prize (including medals and awards)
Activities
-
Optimizing lipid nanoparticle immunotherapy for dendritic cell targeting to enhance CD8⁺ T-cell–mediated anti-tumor immunity
Fredericq, L. (Speaker)
4 May 2026 → 8 May 2026Activity: Talk or presentation › Talk or presentation at a conference
-
SID-in 2026
Fredericq, L. (Participant)
22 Jan 2026Activity: Participating in or organising an event › Participating in or organizing a school event
-
Dag van de Wetenschap
Rolain, I. (Member), Fredericq, L. (Organiser), Geerts, M. (Member), Kelecom, L. (Member), Allonsius, L. (Member), Marcq, E. (Member) & Berghmans, F. (Member)
23 Nov 2025Activity: Participating in or organising an event › Participating in or organizing a festival/exhibition
-
Dag van de Wetenschap
Fredericq, L. (Organiser)
23 Nov 2025Activity: Participating in or organising an event › Participating in or organizing a festival/exhibition
-
SID-in 2025
Fredericq, L. (Member)
23 Jan 2025 → 24 Jan 2025Activity: Participating in or organising an event › Participating in or organizing a school event
Thesis
-
Development of Brca1- and Brca2- deficient triple-negative breast cancer models to assess novel treatment strategies
Laoui, D. (Promotor) & Fredericq, L. ((PhD) Student), Laoui, D. (Promotor) & Deschoemaeker, S. (Advisor), 2023Student thesis: Master's Thesis